Bactericidal Activity of Human Sera against a Brazilian Purpuric Fever (BPF) Strain of Haemophilus influenzae Biogroup aegyptius Correlates with Age-Related Occurrence of BPF

1993 ◽  
Vol 167 (5) ◽  
pp. 1262-1264 ◽  
Author(s):  
L. G. Rubin ◽  
V. B. Peters ◽  
M. C. C. Ferez
2018 ◽  
Vol 43 (1) ◽  
pp. 18-25
Author(s):  
Akram Khan ◽  
Isfahan Tauseef ◽  
Bibi Aalia ◽  
Muhammad Azam Khan ◽  
Sadia Akbar ◽  
...  

1975 ◽  
Vol 21 (10) ◽  
pp. 1587-1594 ◽  
Author(s):  
R. A. Venezia ◽  
R. G. Robertson

During bacteriophage studies on Haemophilus influenzae, it was observed that encapsulated type b and unencapsulated Rb strains released a bactericidal substance active against types a, c, d, e, and f H. influenzae, non-typable H. influenzae strains, other Haemophilus species, and certain members of the Enterobacteriaceae. The bactericidal activity was assayed by a plaque test utilizing an Rd strain as an indicator lawn and was also demonstrated in mixed broth cultures of a producer strain and an indicator strain. Immediate lysis of sensitive bacteria by the factor was not evident. The factor is sensitive to trypsin but resistant to deoxyribonuclease, treatment with 2-mercaptoethanol, lipase, α-amylase, and heating in a 100 °C water bath for 20 min. The activity is not dependent upon increased Ca2+ or Mg2+ concentration as is necessary for HP1C1 and S2 phage propagation. The bactericidal factor is not pelleted by high-speed centrifugation at 150 000 × g for 6 h. Treatment with ultraviolet light or mitomycin C does not result in observable phage, phage-like particles, or increased bactericidal activity. The bactericidal factor is not a typical small molecular weight "colicin-like" bacteriocin in that it is not inducible, has a wider range of activity, and does not kill by "single-hit" kinetics. On preliminary characterization, it is a thermostable protein toxic to certain bacterial strains.


2007 ◽  
Vol 51 (10) ◽  
pp. 3699-3706 ◽  
Author(s):  
M. Torrico ◽  
L. Aguilar ◽  
N. González ◽  
M. J. Giménez ◽  
O. Echeverría ◽  
...  

ABSTRACT The aim of this study was to explore bactericidal activity of total and free serum simulated concentrations after the oral administration of cefditoren (400 mg, twice daily [bid]) versus the oral administration of amoxicillin-clavulanic acid extended release formulation (2,000/125 mg bid) against Haemophilus influenzae. A computerized pharmacodynamic simulation was performed, and colony counts and β-lactamase activity were determined over 48 h. Three strains were used: ampicillin-susceptible, β-lactamase-negative ampicillin-resistant (BLNAR) (also resistant to amoxicillin-clavulanic acid) and β-lactamase-positive amoxicillin-clavulanic acid-resistant (BLPACR) strains, with cefditoren MICs of ≤0.12 μg/ml and amoxicillin-clavulanic acid MICs of 2, 8, and 8 μg/ml, respectively. Against the ampicillin-susceptible and BLNAR strains, bactericidal activity (≥3 log10 reduction) was obtained from 6 h on with either total and free cefditoren or amoxicillin-clavulanic acid. Against the BLPACR strain, free cefditoren showed bactericidal activity from 8 h on. In amoxicillin-clavulanic acid simulations the increase in colony counts from 4 h on occurred in parallel with the increase in β-lactamase activity for the BLPACR strain. Since both BLNAR and BLPACR strains exhibited the same MIC, this was due to the significantly lower (P ≤ 0.012) amoxicillin concentrations from 4 h on in simulations with β-lactamase positive versus negative strains, thus decreasing the time above MIC (T>MIC). From a pharmacodynamic point of view, the theoretical amoxicillin T>MIC against strains with elevated ampicillin/amoxicillin-clavulanic acid MICs should be considered with caution since the presence of β-lactamase inactivates the antibiotic, thus rendering inaccurate theoretical calculations. The experimental bactericidal activity of cefditoren is maintained over the dosing interval regardless of the presence of a mutation in the ftsI gene or β-lactamase production.


1984 ◽  
Vol 3 (6) ◽  
pp. 597
Author(s):  
Tracy L. Gustafson ◽  
Rose A. Kelley ◽  
Robert H. Hutcheson ◽  
William Schaffner ◽  
Sarah H. Sell ◽  
...  

2010 ◽  
Vol 54 (9) ◽  
pp. 3970-3973 ◽  
Author(s):  
Kozue Kishii ◽  
Naoko Chiba ◽  
Miyuki Morozumi ◽  
Akiko Ono ◽  
Takashi Ida ◽  
...  

ABSTRACT In vitro activity of tebipenem, a new oral carbapenem antibiotic, against clinical Haemophilus influenzae isolates was compared with those of 8 reference agents. Isolates were classified into 6 resistance classes after PCR identification of β-lactamase genes and ftsI gene mutations. For all isolates, the minimal concentration at which 90% of isolates were inhibited was lower for tebipenem than for the reference oral antibiotics, except for cefditoren. Tebipenem also showed excellent bactericidal activity against β-lactamase-nonproducing, ampicillin-resistant isolates.


Sign in / Sign up

Export Citation Format

Share Document